DBVT

DBVT

USD

DBV Technologies S.A. American Depositary Shares

$11.010-0.500 (-4.344%)

Real-time Price

Healthcare
Biotechnology
France

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$11.510

High

$11.510

Low

$11.010

Volume

0.02M

Company Fundamentals

Market Cap

301.1M

Industry

Biotechnology

Country

France

Trading Stats

Avg Volume

0.07M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.441Current $11.010High $12.78

Related News

Analyst Upgrades

JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $21 Price Target

JMP Securities analyst Jonathan Wolleben reiterates DBV Technologies with a Market Outperform and maintains $21 price target.

View more
JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $21 Price Target
GlobeNewswire

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old

Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory

View more
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company, today announced upcoming participation in the

View more
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (TRQX:DBVp), a clinical-stage

View more
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting